GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Revenue

Little Green Pharma (ASX:LGP) Revenue : A$25.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma Revenue?

Little Green Pharma's revenue for the six months ended in Mar. 2024 was A$12.98 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was A$25.63 Mil. Little Green Pharma's Revenue per Share for the six months ended in Mar. 2024 was A$0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was A$0.09.

During the past 12 months, the average Revenue per Share Growth Rate of Little Green Pharma was 10.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 71.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Little Green Pharma's highest 3-Year average Revenue per Share Growth Rate was 71.70% per year. The lowest was 71.70% per year. And the median was 71.70% per year.


Little Green Pharma Revenue Historical Data

The historical data trend for Little Green Pharma's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Revenue Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24
Revenue
- 2.20 7.00 19.57 25.63

Little Green Pharma Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24
Revenue Get a 7-Day Free Trial 3.23 7.23 - 12.65 12.98

Competitive Comparison of Little Green Pharma's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Little Green Pharma's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Revenue distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Revenue falls into.



Little Green Pharma Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$25.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Little Green Pharma  (ASX:LGP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Little Green Pharma Revenue Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Little Green Pharma (ASX:LGP) Business Description

Traded in Other Exchanges
N/A
Address
66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines